Evidence map›Paper›PMID 35277051›Full record

ArticleNutrients2022

Antidiabetic Effects of

Miriam Cabello-Olmo, María Oneca, María José Pajares, Maddalen Jiménez, Josune Ayo, Ignacio J Encío, Miguel Barajas, Miriam Araña

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Postbiotic pA1cInternational journal of molecular sciences · 2025
    Article
  4. Heat-InactivatedInternational journal of molecular sciences · 2025
    Article
  5. Whole Genome Analysis ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Probiotics in reducing obesity by reconfiguring the gut microbiota.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Pharmaceutics · 2023
    Article
  14. Article
  15. Review
  16. International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Miriam Cabello-OlmoBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0001-5024-7675
María OnecaGenbioma Aplicaciones SL., 31191 Esquíroz, Spain.ORCID 0000-0003-0949-4804
María José PajaresBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.
Maddalen JiménezDivision of Hematological-Oncology, CIMA, University of Navarre, 31006 Pamplona, Spain.
Josune AyoGenbioma Aplicaciones SL., 31191 Esquíroz, Spain.
Ignacio J EncíoBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0003-1732-1989
Miguel BarajasBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0003-4004-1432
Miriam ArañaBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0002-5363-896X
Universidad Publica de Navarra · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediabetes (PreD), which is associated with impaired glucose tolerance and fasting blood glucose, is a potential risk factor for type 2 diabetes mellitus (T2D). Growing evidence suggests the role of the gastrointestinal microbiota in both PreD and T2D, which opens the possibility for a novel nutritional approach, based on probiotics, for improving glucose regulation and delaying disease progression of PreD to T2D. In this light, the present study aimed to assess the antidiabetic properties of

Indexed as

Diabetes Mellitus, Type 2Pediococcus acidilacticiAnimalsDiet, High-FatHypoglycemic AgentsMiceMice, Inbred C57BLHypoglycemic Agentsdiabetesfasting blood glucosegut microbiota and dysbiosishigh-fat dietinsulin sensitivityPediococcus acidilacticiprediabetesprobiotics

Identifiers

PMID35277051
PMCPMC8839473
OpenAlexW4213056324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.